Can-Fite BioPharma Ltd.

CANF · AMEX
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$8-$8-$10-$13
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0-$0
Stock-Based Comp.$0$0$0$0
Change in WC-$0-$1-$1$2
Other Non-Cash$0-$0$0-$0
Operating Cash Flow-$8-$8-$11-$10
Investing Activities
PP&E Inv.-$0-$0-$0-$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0-$15
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$2$1$10$0
Investing Cash Flow$1$0$10-$15
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$7$9$0$20
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$0$0
Financing Cash Flow$7$9$0$20
Forex Effect-$0$0-$0$0
Net Chg. in Cash$1$1-$1-$4
Supplemental Information
Beg. Cash$4$3$4$8
End Cash$5$4$3$4
Free Cash Flow-$8-$8-$11-$10